Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02363686 · ClinicalTrials.gov registry record · NA

Aspiration in Acute Respiratory Failure Survivors

A NA study of Dysphagia, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
248
Enrollment target
3
Study locations

NCT02363686: Completed NA study of Dysphagia, sponsored by University of Colorado, Denver.

NCT02363686 is a NA study of Dysphagia that has completed, run by University of Colorado, Denver. The registered enrollment target is 248 participants, above the 165-participant average among 35 other Dysphagia trials with a reported enrollment target (50% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02363686, a NA study of Dysphagia, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
248 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe.

Primary Outcome

Aim: To develop a BSE-based non-invasive clinical prediction rule (CPR) that will accurately and efficiently diagnose aspiration in ARF survivors. Aspiration (PAS score of ≥6) on the FEES with any of the five feedings. This outcome measure will report the percentage of participants experiencing silent and non-silent aspiration, as visualized on the FEES. The FEES is a flexible fiberoptic camera that allows the investigators to visualize the patient swallowing each of the 5 different consistencie

Conditions Studied

Interventions

  • PROCEDURE FEES
  • PROCEDURE BSE

Study Locations (3)

Colorado

  • University of Colorado Hospital - Aurora

Connecticut

  • Yale University - New Haven

Massachusetts

  • Boston University Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2012-02
Est. Completion 2020-11-30
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT02363686 record still lists

NCT02363686 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, above the 165-participant average among 35 other Dysphagia trials with a reported enrollment target (50% higher).

The record links to 1 condition, with Dysphagia appearing as the primary indexed condition, and to 2 interventions - of which FEES is the first listed.

NCT02363686 reports a single indexed study location in Colorado, Connecticut, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02363686 about?

NCT02363686 is a clinical study titled "Aspiration in Acute Respiratory Failure Survivors". The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe.

What is the current status of trial NCT02363686?

This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2012-02. Estimated completion is 2020-11-30.

What conditions does trial NCT02363686 study?

This clinical trial studies the following conditions: Dysphagia.

What interventions are being tested in trial NCT02363686?

The interventions under investigation include: FEES (PROCEDURE), BSE (PROCEDURE).

Who is sponsoring clinical trial NCT02363686?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02363686 being conducted?

This trial has 3 study locations across Colorado, Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dysphagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02363686's enrollment target sits among peer trials

248 6th of 35 higher than 30 of 35 other Dysphagia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dysphagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04577911 · 248 participants

    How is Social Connection Represented in the Brain?

  • NCT04777994 · 248 participants · Phase 1

    Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • NCT04792489 · 248 participants · Phase 2

    DALY II USA/ MB-CART2019.1 for DLBCL

  • NCT04830137 · 248 participants · Phase 1

    A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02363686, the US trial registry maintained by the National Library of Medicine. NCT02363686 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.